Nav: Home

Neurotoxic cyanotoxins prevalent in eastern Australian freshwater systems study shows

January 23, 2019

Scientists have confirmed the presence of an amino acid, BMAA, thought to be associated with a higher incidence of neurodegenerative disease, in eastern Australian freshwater systems, and have identified some of the cyanobacterial species responsible for its production.

Detectable levels of BMAA were found in 89% of samples examined, with some samples containing the highest levels ever recorded.

BMAA (β-methylamino-L-alanine) is a toxin produced by cyanobacteria, more commonly known as blue-green algae, which, under the right conditions, grow excessively to form blooms. Such blooms are a regular feature of Australian inland waterways and are increasing due to nutrient run-off, reduced river flows and climate change.

The toxin was first linked to neurodegenerative disease in the 1940s and more recent global studies have implicated BMAA in an increased incidence of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) worldwide.

Eleven freshwater sites from across NSW, including lakes streams creeks and dams, were sampled by researchers from The University of Technology (UTS) to see if it was possible to isolate the cyanobacterial species and create single species cultures that could be tested for these toxins.

Associate Professors Ken Rodgers and Simon Mitrovic, who led the study, said that all the sites were associated with regular blooms and many were from areas that have been tentatively linked to increased incidences of neurodegenerative diseases including Griffith in NSW.

Earlier studies from this research team showed that BMAA, and one of its toxic isomers 2,4-DAB, were present in scum samples from Australian freshwater sites but this is the first time the cyanobacterial species responsible for toxin production have been identified.

From the samples in this study, the primary researcher, Jake Violi, was able to establish 19 single-species cyanobacterial cultures and extract the amino acids for analyses.

The research team from UTS which also included Dr Anne Colville used a highly sensitive analytical method known as liquid-chromatography-tandem mass spectrometry to analyse the samples for the toxins.

Of the 19 cyanobacterial isolates 89% had detectable levels of BMAA and the toxin was detected in at least one culture isolated from each location. Some sites sampled included Anzac Creek in Sydney, Lake Wyangan near Griffith and Lostock Dam in the Hunter Region.

"This shows the prevalence of BMAA in Australian freshwater environments and reflects/accords with results from overseas studies," Jake Violi said.

The research, published in Ecotoxicology and Environmental Safety found the highest concentration of BMAA in cyanobacterial isolates reported in the published literature.

The researchers conclude that the prevalence, abundance and high concentrations of the cyanotoxins found in Eastern Australian freshwater environments necessitates ongoing monitoring and analysis so that safe levels can be determined and guidelines established.
-end-


University of Technology Sydney

Related Neurodegenerative Disease Articles:

Special issue of Future Medicinal Chemistry explores advances in neurodegenerative disease therapy
Future Medicinal Chemistry, a leading MEDLINE indexed journal for medicinal chemists, has published two Special Focus issues on Medicinal Chemistry Advances in Neurodegenerative Disease Therapy.
Neurodegenerative disease mechanism and potential drug identified
Two new, UC Davis-led studies of neurodegenerative diseases linked to mitochondrial defects offer hope for developing a new biomarker for research and diagnostics, and a drug for treating such diseases.
Biomarker test for ALS useful in diagnosing canine neurodegenerative disease
In 2009, Joan Coates, a veterinary neurologist, along with other researchers at the University of Missouri and the Broad Institute at MIT/Harvard, found a genetic link between degenerative myelopathy (DM) in dogs and amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
Common factor links neurodegenerative disease in young and old
Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), identified a common mechanism in two forms of neurodegeneration that affect young adults or the elderly.
Doctoral student's research looks at cause of neurodegenerative disease
A Kansas State University student hopes her research on a currently untreatable and progressive neurodegenerative disease will one day lead to treatment options.
Turning off the protein tap -- A new clue to neurodegenerative disease
Disabling a part of brain cells that acts as a tap to regulate the flow of proteins has been shown to cause neurodegeneration, a new study from The University of Manchester has found.
Potential Alzheimer's medication shows promise in mouse model of neurodegenerative disease
This month in the JCI, work led by Andrew Tobin at the University of Leicester tested two drugs that specifically target the M1 muscarinic acetylcholine receptor in a mouse model of Alzheimer's disease and discovered that the treatments had promising effects on symptoms of cognitive decline.
Stanford patient is first infant to receive lifesaving drug for neurodegenerative disease
Four-year-old Zoe Harting is doing well after participating in a phase-2 clinical trial of the first drug for a deadly genetic disease, spinal muscular atrophy type 1.
Mutant prion protein could help reveal neurodegenerative disease mechanisms
For the first time, scientists have isolated a mutated prion protein that can multiply in the lab but not in living animals, according to a PLOS Pathogens study.
Toxic peptides disrupt membrane-less organelles in neurodegenerative disease
St. Jude Children's Research Hospital scientists reveal how toxic peptides that arise due to amyotrophic lateral sclerosis and frontotemporal dementia target the integrity of membrane-less organelles and trigger disease.

Related Neurodegenerative Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".